FDA Investigator

Elisa M Fleming

Latest inspection on record: Longview, United States, February 2025 · records back to 2009

Human DrugsBiologicsAnimal Drugs & FeedsMedical Devices & Rad HealthFoods & Cosmetics

FDA inspection record · Last updated July 12, 2026

Overview

  • 103 inspections across 98 sites are on record.
  • 216 Form 483 observations are attributed to this investigator.
  • Most recent recorded activity is 2025-02-13.

At a glance

Inspections

103

Sites

98

Observations

216

Career since

Apr 2009

Recent inspections

Most recent inspections in the published record.

SiteDateCategoryForm 483
Carter BloodCare - Longview13 Feb 2025Biologics
IndeCon, Inc.12 Dec 2024BiologicsView 483 →
Reproductive Services Of Indiana, Inc20 Jan 2023BiologicsView 483 →
GC Labtech6 Feb 2019Biologics
Roy M Fleischmann, Dr14 Jun 2016Human Drugs

Sites inspected

Carter BloodCare - LongviewLongview, United States1 insp.
IndeCon, Inc.Dallas, United States1 insp.
Reproductive Services Of Indiana, IncCarmel, United States1 insp.
GC LabtechSan Antonio, United States1 insp.
Roy M Fleischmann, DrDallas, United States1 insp.

Co-investigators

Investigators who share inspections with this person.

Young M Yoon10 shared
Danny D Horner4 shared
Christopher J Smith2 shared

Full investigator report

Get the verbatim findings behind Elisa M Fleming's 216 observations

Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.

  • New inspections and Form 483s, mapped to the CFR citation
  • Warning letter outcomes, and the citation patterns they repeat
  • Their co-investigators, so no surprises about who shows up on site